Friday June 5, 2020

Politicians shouldn’t play God with drugs funding

Prioritising one patient group - perhaps because of the power of their advocacy - means another group will lose out, even if their case for funding is much stronger

3rd February, 2019

The process by which new, innovative medicines are made available to patients through the health service is broken. It was broken by the Department of Health’s failure to plan ahead for the pipeline of new, reimbursable drugs, and by political meddling that has undermined the credibility of what should be an evidence-based, clinically validated process of priority-setting solely according to health benefit.

Superficially, this might seem like a technical squabble among civil servants...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Many of us have achieved a new life balance that might just be the real ‘new normal’

Sharyn McAndrew | 2 weeks ago

Property firms such as QRE are dealing with the coronavirus lockdown by trying to maintain some normality in their day-to-day business

Conor Whelan | 3 weeks ago

Hardline opposition to EU solidarity in funding the cost of Covid-19 is driven by German allergy to ‘imprudent’ spending, and by Dutch politicians fearing the transfer of funds to southern countries would provoke a far-right backlash

Barry J Whyte | 1 month ago